Introduction
Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by three types (L1, L2 and L3) of the bacterium Chlamydia trachomatis (CT). The classical presentation of LGV is inguinal lymphadenitis and abscess formation sometimes preceded by anogenital ulceration. 1 Classic LGV infections have been uncommon in Western countries, but in 2003 initial clusters of LGV cases in men who have sex with men (MSM) were reported in the Netherlands followed by a series of outbreaks in Europe, North America and Australia, mainly among HIV-positive MSM. We report here the first case of LGV in Lebanon in an HIV-negative MSM. [1] [2] [3] Case A 43-year-old man presented with a 3-day history of a small painless penile ulcer. He reported unprotected oral sex 2 weeks previously with a casual male partner in Europe. He was an otherwise healthy patient who worked as a flight attendant and travelled a lot. His last STI tests performed one month prior to his presentation were all negative. Since his last STI screen, he had one oral insertive and receptive intercourse (with sexual rubbing at the end but without anal intercourse) in Europe (Paris) and one receptive protected oral intercourse in Thailand.
Clinical examination showed an erythematous ulcer that was not tender and not indurated. There were no palpable lymph nodes (Figure 1 ). Pharyngeal and rectal mucosae were normal. Urine testing, ulcer and rectal and pharyngeal swabs were performed with polymerase chain reaction (PCR) testing for CT, Neisseria gonorrhoeae (NG), Herpes Simplex Virus 1 and 2 and Treponema pallidum. Serologic tests for syphilis, HIV, HBV and HCV were all negative. All PCR results were negative except for the ulcer swab: it was positive for CT by strand displacement amplification (CTSDA) using BD ProbeTec system. The CT was confirmed as serovar L2b using an LGV-specific pmpH real-time PCR assay. The patient was commenced on 3 weeks of twice daily oral doxycycline in line with a diagnosis of LGV. He was asked to strictly avoid any sexual intercourse for 4 weeks. Contact tracing was not successful as the patient did not have the casual partner's details. On a 4-week follow-up examination, the ulcer had resolved. Two weeks later, his test of cure was negative for CT.
Discussion
Despite the predominance of anorectal disease reported, clinical manifestations of LGV have not been confined to proctitis in the current outbreak in MSM. 4 This case highlights the need for awareness of LGV as a cause of genital ulceration in a high-risk population.
Our patient was HIV negative; HIV-positive status appears more related to proctitis cases than to genital ulcer. 4 The mode of transmission in our case was not certain; it could have been the oral sex (receptive and insertive) which feasibly could transmit LGV by this route, 5 or it could be from the sexual rubbing he reported. A positive pharyngeal or anal swab from the sexual partner might have assisted in determining the likely mode of transmission.
A large study in MSM from London and Brighton showed an estimated prevalence of LGV of 0.90% in the rectum and only 0.04% in the urethra. 6 The prevalence of pharyngeal CT in London MSM is low at 1.2% 7 ; only 12% of these patients reported throat symptoms at the time of their testing.
The genital ulceration associated with LGV is transient and often overlooked, and chlamydia is infrequently found elsewhere during standard STI screening of the urethra, rectum or cervix in these patients.
A 3-week course of doxycycline is the recommended treatment for LGV. 7 In Lebanon, the standard STI screen for MSM consists of HIV, HBV, HCV and syphilis serologies with CT and NG DNA tests from urine, throat and anus.
There is no access to routine typing for LGV DNA in MSM and thus, cases of LGV proctitis in MSM would be missed. We report here the first case of LGV in Lebanon in an HIV-negative MSM.
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